OBJECTIVE: Translating lessons from clinical trials on the prevention or delay of type 2 diabetes to populations in nonstudy settings
remains a challenge. The purpose of this paper is to review, from the perspective of practicing clinicians, available evidence
on lifestyle interventions or medication to prevent or delay the onset of type 2 diabetes.
DESIGN: A MEDLINE search identified 4 major diabetes prevention trials using lifestyle changes and 3 using prophylactic medications.
We reviewed the study design, key components, and outcomes for each study, focusing on aspects of the interventions potentially
adaptable to clinical settings.
RESULTS: The lifestyle intervention studies set modest goals for weight loss and physical activity. Individualized counseling helped
participants work toward their own goals; behavioral contracting and self-monitoring were key features, and family and social
context were emphasized. Study staff made vigorous follow-up efforts for subjects having less success. Actual weight loss
by participants was modest; yet, the reduction in diabetes incidence was quite significant. Prophylactic medication also reduced
diabetes risk; however, lifestyle changes were more effective and are recommended as first-line strategy. Cost-effectiveness
analyses have shown both lifestyle and medication interventions to be beneficial, especially as they might be implemented
in practice.
CONCLUSION: Strong evidence exists for the prevention or delay of type 2 diabetes through lifestyle changes. Components of these programs
may be adaptable for use in clinical settings. This evidence supports broader implementation and increased reimbursement for
provider services related to nutrition and physical activity to forestall morbidity from type 2 diabetes.
Key Words type 2 diabetes - prevention - lifestyle - nutrition - physical activity
This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Research and Training
Center (P60 DK20595). Dr. Burnet is supported by a Mentored, Patient Oriented, Career Development Award (K23 DK064073-01),
and Dr. Chin was a Robert Wood Johnson Foundation Generalist Physician Faculty Scholar.